ntersuchung der Wirksamkeit einer glycerinhaltigen Creme bei der Behandlung von Atopischer Dermatitis. Kontrolliert, randomisierte Doppel-Blind-Studie.
Phase 1
- Conditions
- Atopic DermatitisMedDRA version: 7.0Classification code 10012438
- Registration Number
- EUCTR2004-004443-22-DE
- Lead Sponsor
- Spirig Pharma AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
atopic dermatitis,
informed consent,
12-50 years old,
male or female
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
allergy against an ingredient,
pregnancy, breastfeding,
systemic illness,
malignant tumor
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: barrier recovery in subjects with atopic dermatitis;Secondary Objective: reduction of inflammation, hydration of stratum corneum, stabilisation of skin-pH;Primary end point(s): end of study after 4 weeks of therapy and two weeks without treatment
- Secondary Outcome Measures
Name Time Method